logo

Oragenics Inc. (OGEN)



Trade OGEN now with
  Date
  Headline
7/22/2020 7:38:03 AM Oragenics: Study Shows SARS-CoV-2 Spike Protein Licensed By Company From NIH Produces Neutralizing Antibodies
7/10/2020 7:38:28 AM Oragenics Continues Development Of TerraCoV2, Goal Of Bringing COVID-19 Vaccine Candidate Into Humantrials By Early 2021
5/4/2020 6:18:16 AM Oragenics Appoints Kim Murphy To Board
5/4/2020 6:03:40 AM Oragenics Acquires Noachis Terra Inc.
4/15/2020 6:35:35 AM Oragenics Reports Early Top-line Results Of Phase 2 Clinical Trial Of AG013
12/2/2019 8:38:06 AM Oragenics Completes Enrollment In Ongoing Phase 2 Trial Of Its Lead Product Candidate, AG013
9/25/2019 8:12:55 AM Oragenics Enrolls 158 Patients In Its Phase 2 Trial Of AG013 For Severe Oral Mucositis
3/21/2019 6:06:30 AM Oragenics Reports Pricing Of $12.5 Mln Public Offering
10/17/2018 7:34:47 AM Oragenics Gets Clearance To Enroll Patients In Belgium Into Its Phase 2 Clinical Trial Of AG013 For Oral Mucositis
8/15/2018 7:31:46 AM Oragenics Resumes Phase 2 Clinical Trial Of AG013